Application of hepatic cytochrome b5/P450 reductase null (HBRN) mice to study the role of cytochrome b5 in the cytochrome P450-mediated bioactivation of the anticancer drug ellipticine
- Lindsay Reed
- , Radek Indra
- , Iveta Mrizova
- , Michaela Moserova
- , Heinz H. Schmeiser
- , C. Roland Wolf
- , Colin J. Henderson
- , Marie Stiborova
- , David H. Phillips
- , Volker M. Arlt (Lead / Corresponding author)
Research output: Contribution to journal › Article › peer-review
3
Link opens in a new tab
Citations
(Scopus)
240
Downloads
(Pure)